ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

$ 28.00

5 (632) In stock

Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint Neuro Maestro Brain Model Comparative Reproducibility Error Results Reproducibility error of Maestro (green), FreeSurfer 7.2 (blue) and manual segmentation (red) for common brain structures (left), and average over all structures (right). Bars represent range of measured relative volume difference. SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NE
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint

ClearPoint Neuro (CLPT) Gets FDA's Nod for SmartFrame OR System

SNN

Jacqueline Keller on LinkedIn: Welcome! You are invited to join a webinar: Data Driven Evolution of…

ClearPoint Neuro Announces FDA Clearance and First-in-Human

Jacqueline Keller on LinkedIn: Two great pieces of news: 1) FDA clearance and FIH for our new 2.2…

Jacqueline Keller on LinkedIn: So proud of our teammates who applied over a decade of ClearPoint…

SNN

ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe

ClearPoint Neuro, Inc. on LinkedIn: Doctors test experimental treatment to combat seizures in epilepsy patients

CLPT - ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock